Use of Bipolar Radiofrequency Catheter Ablation in the Treatment of Cardiac Arrhythmias

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F18%3A00069306" target="_blank" >RIV/00159816:_____/18:00069306 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216224:14110/18:00104054

Výsledek na webu

<a href="http://dx.doi.org/10.2174/1573403X14666180524100608" target="_blank" >http://dx.doi.org/10.2174/1573403X14666180524100608</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.2174/1573403X14666180524100608" target="_blank" >10.2174/1573403X14666180524100608</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Use of Bipolar Radiofrequency Catheter Ablation in the Treatment of Cardiac Arrhythmias

Popis výsledku v původním jazyce

Background: Arrhythmia management is a complex process involving both pharmacological and non-pharmacological approaches. Radiofrequency ablation is the pillar of non-pharmacological arrhythmia treatment. Unipolar ablation is considered to be the gold standard in the treatment of the majority of arrhythmias; however, its efficacy is limited to specific cases. In particular, the creation of deep or transmural lesions to eliminate intramurally originating arrhythmias remains inadequate. Bipolar ablation is proposed as an alternative to overcome unipolar ablation boundaries. Results: Despite promising results gained from in vitro and animal studies showing that bipolar ablation is superior in creating transmural lesions, the use of bipolar ablation in daily clinical practice is limited. Several studies have been published showing that bipolar ablation is effective in the treatment of clinical arrhythmias after failed unipolar ablation, however, there is inconsistency regarding the safety of bipolar ablation within the available research papers. According to research evidence, the most common indications for bipolar ablation use are ventricular originating rhythmic disorders in patients with structural heart disease resistant to standard radiofrequency ablation. Conclusion: To allow wider clinical application the efficiency and safety of bipolar ablation need to be verified in future studies.

Název v anglickém jazyce

Use of Bipolar Radiofrequency Catheter Ablation in the Treatment of Cardiac Arrhythmias

Popis výsledku anglicky

Background: Arrhythmia management is a complex process involving both pharmacological and non-pharmacological approaches. Radiofrequency ablation is the pillar of non-pharmacological arrhythmia treatment. Unipolar ablation is considered to be the gold standard in the treatment of the majority of arrhythmias; however, its efficacy is limited to specific cases. In particular, the creation of deep or transmural lesions to eliminate intramurally originating arrhythmias remains inadequate. Bipolar ablation is proposed as an alternative to overcome unipolar ablation boundaries. Results: Despite promising results gained from in vitro and animal studies showing that bipolar ablation is superior in creating transmural lesions, the use of bipolar ablation in daily clinical practice is limited. Several studies have been published showing that bipolar ablation is effective in the treatment of clinical arrhythmias after failed unipolar ablation, however, there is inconsistency regarding the safety of bipolar ablation within the available research papers. According to research evidence, the most common indications for bipolar ablation use are ventricular originating rhythmic disorders in patients with structural heart disease resistant to standard radiofrequency ablation. Conclusion: To allow wider clinical application the efficiency and safety of bipolar ablation need to be verified in future studies.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

<a href="/cs/project/LQ1605" target="_blank" >LQ1605: Translační medicína</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2018

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Current Cardiology Reviews

ISSN

1573-403X

e-ISSN

—

Svazek periodika

14

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

NL - Nizozemsko

Počet stran výsledku

7

Strana od-do

185-191

Kód UT WoS článku

000441096000005

EID výsledku v databázi Scopus

—